Media Newsroom of

Greystone Research Associates

98 Route 101A
Amherst, NH 03031
Phone: 603-595-4340
Website: http://www.greystoneassociates.org

Greystone Research Associates is a medical technology consulting firm supplying guidance, direction and market knowledge to Pharmaceutical and Biotech companies.

As the Market Prepares for New Regulations Closed System Drug Transfer Set to Grow at CAGR of 10.6 Percent to 2024

As the Market Prepares for New Regulations Closed System Drug Transfer Set to Grow at CAGR of 10.6 Percent to 2024

The risks to patients and caregivers posed by selected drug classes that include cytotoxic drugs routinely used in the treatment of oncology have been known for some time. Drug handling systems¬†commonly known as closed system drug transfer (CSDT) devices, introduced…

Driven by Demographics and Economics Subcutaneous Injection Markets to Reach 7 Billion Units in 2024

Driven by Demographics and Economics Subcutaneous Injection Markets to Reach 7 Billion Units in 2024

The evolution in drug-injection devices to accommodate new injectable drugs continues to change the therapeutic drug landscape. Device designers are now building on the experience of earlier generations of syringes and injectors, incorporating new design features with the aim of…

Dual Chamber Injection Device Market to Reach $5.3 Billion by 2024

Dual Chamber Injection Device Market to Reach $5.3 Billion by 2024

The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients have led to increasing interest in injection devices that can eliminate the number of steps required to convert…

On-Body Subcutaneous Injection Systems Positioned to Prosper as Dosage Volumes Push Past the 2 mL Barrier

On-Body Subcutaneous Injection Systems Positioned to Prosper as Dosage Volumes Push Past the 2 mL Barrier

As drug developers widen the therapeutic envelope to create effective treatments for intractable disease targets, they are finding it necessary to move beyond traditional limits on drug formulation and dosing. The result is often specified doses that are beyond the…

Greystone Research Associates: Self Injection Systems Adapting to Address the Dosing Challenges of Evolving Therapeutics

Greystone Research Associates: Self Injection Systems Adapting to Address the Dosing Challenges of Evolving Therapeutics

In response to new and emerging drug classes, evolving formulations and patient safety initiatives, the injectable drug segment has seen a marked increase in the level of drug/device integration and feature expansion, according to Greystone Research Associates. Some of these…

Convergence of Sensor Enabled Devices and Predictive Data Set to Advance Chronic Respiratory Patient Care

Convergence of Sensor Enabled Devices and Predictive Data Set to Advance Chronic Respiratory Patient Care

Converging technologies are creating new ways for patients diagnosed with chronic upper respiratory illnesses to improve outcomes while avoiding external factors that may exacerbate or trigger their conditions. These complementary patient care modalities, most of which are in the early…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login